Thiabendazole + Dexamethasone + Neomycin
139 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
139
Total Reports
8
Deaths Reported
580.0%
Death Rate
Active Ingredients
Thiabendazole + Dexamethasone + Neomycin
Administration Routes
Auricular (Otic)UnknownTopicalOral
Species Affected
Dog 85
Cat 53
Ferret 1
Most Affected Breeds
Domestic Shorthair 28
Retriever - Golden 7
Domestic Longhair 7
Maltese 6
Pug 6
Chihuahua 5
Boxer (German Boxer) 4
Shih Tzu 4
Pit Bull 4
Foxhound - American 4
Most Reported Reactions
Emesis 31
Vomiting 21
Lethargy (see also Central nervous system depression in 'Neurological') 20
Behavioural disorder NOS 14
Lack of efficacy - NOS 12
Lethargy (see also Central nervous system depression in Neurological) 11
Other abnormal test result NOS 10
Ear infection NOS 10
Decreased appetite 9
Not eating 8
Diarrhoea 7
Ataxia 7
Outcome Breakdown
Recovered/Normal
60 (43.2%)
Outcome Unknown
34 (24.5%)
Ongoing
34 (24.5%)
Died
6 (4.3%)
Recovered with Sequela
3 (2.2%)
Euthanized
2 (1.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.